University of Glasgow (Institute of Cancer Sciences)

University of Glasgow (Institute of Cancer Sciences)

University of Glasgow (Institute of Cancer Sciences)

Thumbnail image for University of Glasgow (Institute of Cancer Sciences)

The University of Glasgow's Institute of Cancer Sciences undertakes research of international quality directed at key aspects of cancer cell behaviour with the ambition of forging new therapies and diagnostic tools to help cancer sufferers. The University has identified cancer as one of its key strategic themes and there has been major investment into cancer research over the past decade (including substantial investments from the Wolfson Foundation).

In 2008 the Foundation awarded £1.75 million to help create a new building focussed particularly on translational research: the Wolfson Wohl Cancer Research Centre. Previous investments have included £2 million in 2004 and £410,000 in 1973 towards the Beatson Institute of Cancer Research which is also located on the site.

The new Wolfson Wohl Centre opened early in 2013 when its first director, Professor Andrew Biankin (who will be Professor of Surgery), took up post. Professor Biankin came from the Garvan Institute of Medical Research, New South Wales, Sydney.

University of Glasgow (The Institute of Cancer Sciences)